360 High-Risk Vulnerability Immunization Tool V2.0 vs DeployHub Automated Vulnerability Detection Platform: 2026 Comparison

360 High-Risk Vulnerability Immunization Tool V2.0

Startups and SMBs with Windows-heavy infrastructure and patching backlogs should run 360 High-Risk Vulnerability Immunization Tool V2.0 first; it immunizes against the specific CVEs that drive ransomware campaigns (MS17-010, CVE-2019-0708) without requiring immediate OS updates. The tool supports Windows 7 through current versions and deploys on-premises, meaning air-gapped networks can actually use it. Skip this if you're looking for NIST PR.PS coverage beyond platform hardening,this tool stops known exploits, not supply chain attacks or firmware-level threats.

DeployHub Automated Vulnerability Detection Platform

Mid-market and enterprise teams managing polyglot deployments across multiple environments should use DeployHub Automated Vulnerability Detection Platform for its ability to map vulnerabilities directly to live running services rather than leaving findings orphaned in container registries or artifact repos. The platform's real-time CVE correlation with active endpoints and SBOM aggregation across environments means your team stops chasing inventory ghosts and starts knowing what's actually exposed. Skip this if you need pre-deployment scanning as your primary control; DeployHub assumes vulnerabilities will slip through to production and catches them there instead.